| 0 |
FLANK DISCOMFORT |
1 |
0.1667 |
| 1 |
HUMAN PAPILLOMAVIRUS REACTIVATION |
1 |
0.0769 |
| 2 |
ABDOMINAL WALL PAIN |
1 |
0.0588 |
| 3 |
HANTAVIRAL INFECTION |
1 |
0.0476 |
| 4 |
VACCINATION SITE PRURITUS |
1 |
0.0196 |
| 5 |
DRUG-DEVICE INTERACTION |
2 |
0.0180 |
| 6 |
CSF SHUNT OPERATION |
1 |
0.0139 |
| 7 |
DEVICE TEMPERATURE ISSUE |
1 |
0.0133 |
| 8 |
IMPLANTABLE CARDIAC MONITOR INSERTION |
1 |
0.0088 |
| 9 |
VENTRICULO-PERITONEAL SHUNT |
1 |
0.0088 |
| 10 |
EXTERNAL EAR PAIN |
1 |
0.0085 |
| 11 |
CYTOTOXIC LESIONS OF CORPUS CALLOSUM |
1 |
0.0068 |
| 12 |
CREATININE URINE DECREASED |
1 |
0.0063 |
| 13 |
EAR INFECTION VIRAL |
1 |
0.0063 |
| 14 |
CORONAVIRUS PNEUMONIA |
1 |
0.0060 |
| 15 |
INJECTION SITE COLDNESS |
5 |
0.0059 |
| 16 |
ORAL BACTERIAL INFECTION |
1 |
0.0055 |
| 17 |
SUSPECTED DRUG-INDUCED LIVER INJURY |
1 |
0.0050 |
| 18 |
SLEEVE GASTRECTOMY |
1 |
0.0041 |
| 19 |
NON-HIGH-DENSITY LIPOPROTEIN CHOLESTEROL INCREASED |
1 |
0.0037 |
| 20 |
EYE INFECTION VIRAL |
1 |
0.0031 |
| 21 |
BLOOD TRIGLYCERIDES DECREASED |
1 |
0.0030 |
| 22 |
COLOUR BLINDNESS ACQUIRED |
1 |
0.0028 |
| 23 |
DENTAL DISCOMFORT |
2 |
0.0024 |
| 24 |
TEMPOROMANDIBULAR PAIN AND DYSFUNCTION SYNDROME |
1 |
0.0023 |
| 25 |
TREATMENT DELAYED |
4 |
0.0023 |
| 26 |
BLOOD ALBUMIN INCREASED |
2 |
0.0022 |
| 27 |
RESPIRATORY SYMPTOM |
6 |
0.0021 |
| 28 |
PROTEIN URINE PRESENT |
10 |
0.0020 |
| 29 |
TRI-IODOTHYRONINE DECREASED |
1 |
0.0019 |
| 30 |
ASPARTATE AMINOTRANSFERASE DECREASED |
1 |
0.0019 |
| 31 |
ENDOSCOPY |
1 |
0.0017 |
| 32 |
INJECTION SITE DISCOMFORT |
17 |
0.0016 |
| 33 |
NASAL PRURITUS |
2 |
0.0016 |
| 34 |
NASAL CRUSTING |
1 |
0.0015 |
| 35 |
BLOOD IMMUNOGLOBULIN A DECREASED |
1 |
0.0015 |
| 36 |
GINGIVAL DISCOMFORT |
1 |
0.0015 |
| 37 |
IMMUNOGLOBULINS DECREASED |
2 |
0.0015 |
| 38 |
H1N1 INFLUENZA |
2 |
0.0014 |
| 39 |
INJECTION SITE HYPOAESTHESIA |
2 |
0.0014 |
| 40 |
ALANINE AMINOTRANSFERASE DECREASED |
1 |
0.0014 |
| 41 |
TENDON DISCOMFORT |
1 |
0.0013 |
| 42 |
MUSCLE DISCOMFORT |
1 |
0.0013 |
| 43 |
SUPERINFECTION BACTERIAL |
1 |
0.0013 |
| 44 |
BLOOD IMMUNOGLOBULIN G DECREASED |
3 |
0.0012 |
| 45 |
HAND-FOOT-AND-MOUTH DISEASE |
1 |
0.0012 |
| 46 |
OOPHORECTOMY |
1 |
0.0011 |
| 47 |
SALIVA ALTERED |
1 |
0.0011 |
| 48 |
INJECTION SITE DRYNESS |
1 |
0.0011 |
| 49 |
PROTEIN URINE |
1 |
0.0011 |
| 50 |
URINE ABNORMALITY |
5 |
0.0011 |
| 51 |
SUSPECTED PRODUCT QUALITY ISSUE |
2 |
0.0011 |
| 52 |
DISTURBANCE IN SEXUAL AROUSAL |
1 |
0.0011 |
| 53 |
LUPUS NEPHRITIS |
2 |
0.0011 |
| 54 |
INJECTION SITE SCAB |
1 |
0.0010 |
| 55 |
UPPER RESPIRATORY TRACT CONGESTION |
3 |
0.0010 |
| 56 |
BLOOD IMMUNOGLOBULIN M DECREASED |
1 |
0.0010 |
| 57 |
INJECTION SITE SWELLING |
75 |
0.0010 |
| 58 |
SINUSITIS BACTERIAL |
1 |
0.0009 |
| 59 |
GASTROINTESTINAL ULCER |
2 |
0.0009 |
| 60 |
CARBON DIOXIDE DECREASED |
1 |
0.0009 |
| 61 |
CHEMICAL BURN |
1 |
0.0009 |
| 62 |
MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE |
2 |
0.0008 |
| 63 |
FEAR OF INJECTION |
6 |
0.0008 |
| 64 |
URINE FLOW DECREASED |
2 |
0.0008 |
| 65 |
RENAL TRANSPLANT |
3 |
0.0008 |
| 66 |
BLEEDING TIME PROLONGED |
1 |
0.0008 |
| 67 |
PHARYNGEAL INFLAMMATION |
1 |
0.0008 |
| 68 |
ALLERGY TO CHEMICALS |
1 |
0.0008 |
| 69 |
LIP DISCOLOURATION |
1 |
0.0008 |
| 70 |
GLUCOSE URINE PRESENT |
1 |
0.0008 |
| 71 |
NOCTURNAL DYSPNOEA |
1 |
0.0008 |
| 72 |
PROTEIN TOTAL ABNORMAL |
1 |
0.0008 |
| 73 |
PRODUCT PACKAGING DIFFICULT TO OPEN |
2 |
0.0008 |
| 74 |
INJECTION SITE DISCHARGE |
4 |
0.0007 |
| 75 |
VULVOVAGINAL CANDIDIASIS |
1 |
0.0007 |
| 76 |
SKIN WRINKLING |
2 |
0.0007 |
| 77 |
INJECTION SITE PRURITUS |
47 |
0.0007 |
| 78 |
NOROVIRUS INFECTION |
1 |
0.0007 |
| 79 |
BLOOD CREATINE INCREASED |
3 |
0.0007 |
| 80 |
CUSHINGOID |
2 |
0.0006 |
| 81 |
INJECTION SITE RASH |
19 |
0.0006 |
| 82 |
PRODUCT PREPARATION ISSUE |
4 |
0.0006 |
| 83 |
TONSILLAR HYPERTROPHY |
1 |
0.0006 |
| 84 |
FOOD AVERSION |
1 |
0.0006 |
| 85 |
SKIN WOUND |
1 |
0.0006 |
| 86 |
ENTERITIS INFECTIOUS |
1 |
0.0006 |
| 87 |
GLOMERULAR FILTRATION RATE DECREASED |
7 |
0.0006 |
| 88 |
TERMINAL INSOMNIA |
1 |
0.0006 |
| 89 |
INTRA-ABDOMINAL FLUID COLLECTION |
1 |
0.0006 |
| 90 |
NASAL OBSTRUCTION |
1 |
0.0005 |
| 91 |
PROTEIN TOTAL DECREASED |
2 |
0.0005 |
| 92 |
INJECTION SITE URTICARIA |
13 |
0.0005 |
| 93 |
PRODUCT STORAGE ISSUE |
2 |
0.0005 |
| 94 |
INJECTION SITE VESICLES |
3 |
0.0005 |
| 95 |
ESCHERICHIA INFECTION |
4 |
0.0005 |
| 96 |
INJECTION SITE DISCOLOURATION |
6 |
0.0005 |
| 97 |
UPPER RESPIRATORY TRACT INFECTION |
22 |
0.0005 |
| 98 |
EYE CONTUSION |
1 |
0.0005 |
| 99 |
OLIGOMENORRHOEA |
1 |
0.0005 |
| 100 |
IDIOPATHIC INTRACRANIAL HYPERTENSION |
1 |
0.0004 |
| 101 |
NECK SURGERY |
1 |
0.0004 |
| 102 |
RESPIRATORY TRACT INFECTION VIRAL |
1 |
0.0004 |
| 103 |
SINUS PAIN |
1 |
0.0004 |
| 104 |
TRANSPLANT |
1 |
0.0004 |
| 105 |
LYMPHADENITIS |
1 |
0.0004 |
| 106 |
INJECTION SITE ERYTHEMA |
51 |
0.0004 |
| 107 |
SUFFOCATION FEELING |
1 |
0.0004 |
| 108 |
INJECTION SITE INFLAMMATION |
2 |
0.0004 |
| 109 |
INJECTION SITE BRUISING |
32 |
0.0004 |
| 110 |
KLEBSIELLA INFECTION |
2 |
0.0004 |
| 111 |
INJECTION SITE IRRITATION |
5 |
0.0004 |
| 112 |
INJECTION SITE INDURATION |
5 |
0.0004 |
| 113 |
RENAL PAIN |
4 |
0.0004 |
| 114 |
PROTEIN TOTAL INCREASED |
1 |
0.0004 |
| 115 |
BREAST SWELLING |
1 |
0.0004 |
| 116 |
PROTEINURIA |
7 |
0.0004 |
| 117 |
RHINALGIA |
1 |
0.0004 |
| 118 |
PERIORBITAL SWELLING |
2 |
0.0004 |
| 119 |
DIALYSIS |
5 |
0.0004 |
| 120 |
INJECTION SITE SCAR |
1 |
0.0004 |
| 121 |
PRODUCT ADMINISTRATION ERROR |
7 |
0.0003 |
| 122 |
IMMUNOSUPPRESSION |
3 |
0.0003 |
| 123 |
ENERGY INCREASED |
2 |
0.0003 |
| 124 |
ACNE CYSTIC |
1 |
0.0003 |
| 125 |
PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
2 |
0.0003 |
| 126 |
DERMATITIS ACNEIFORM |
2 |
0.0003 |
| 127 |
INJECTION SITE PAIN |
100 |
0.0003 |
| 128 |
FLANK PAIN |
3 |
0.0003 |
| 129 |
INJECTION SITE HYPERSENSITIVITY |
1 |
0.0003 |
| 130 |
FOREIGN BODY IN THROAT |
1 |
0.0003 |
| 131 |
BLOOD URINE PRESENT |
6 |
0.0003 |
| 132 |
UNDERDOSE |
23 |
0.0003 |
| 133 |
BLOOD POTASSIUM INCREASED |
5 |
0.0003 |
| 134 |
SKIN INJURY |
1 |
0.0003 |
| 135 |
HIGH DENSITY LIPOPROTEIN DECREASED |
1 |
0.0003 |
| 136 |
LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV |
1 |
0.0003 |
| 137 |
SEASONAL ALLERGY |
4 |
0.0003 |
| 138 |
LIQUID PRODUCT PHYSICAL ISSUE |
2 |
0.0003 |
| 139 |
CUTANEOUS VASCULITIS |
1 |
0.0003 |
| 140 |
ARTHROPOD BITE |
2 |
0.0003 |
| 141 |
OESOPHAGEAL DISORDER |
1 |
0.0003 |
| 142 |
RHINORRHOEA |
16 |
0.0002 |
| 143 |
GALLBLADDER OPERATION |
1 |
0.0002 |
| 144 |
INJECTION SITE WARMTH |
5 |
0.0002 |
| 145 |
GENERALISED OEDEMA |
3 |
0.0002 |
| 146 |
SPINAL STENOSIS |
1 |
0.0002 |
| 147 |
LABORATORY TEST ABNORMAL |
7 |
0.0002 |
| 148 |
INTESTINAL STENOSIS |
1 |
0.0002 |
| 149 |
MUSCLE FATIGUE |
1 |
0.0002 |
| 150 |
POOR PERIPHERAL CIRCULATION |
1 |
0.0002 |
| 151 |
NASOPHARYNGITIS |
43 |
0.0002 |
| 152 |
EXPOSURE VIA SKIN CONTACT |
6 |
0.0002 |
| 153 |
HORDEOLUM |
1 |
0.0002 |
| 154 |
GROIN PAIN |
2 |
0.0002 |
| 155 |
DEVICE DIFFICULT TO USE |
15 |
0.0002 |
| 156 |
EAR INFECTION |
6 |
0.0002 |
| 157 |
ILLNESS |
23 |
0.0002 |
| 158 |
CHROMATURIA |
5 |
0.0002 |
| 159 |
PAPILLOEDEMA |
1 |
0.0002 |
| 160 |
BLOOD THYROID STIMULATING HORMONE DECREASED |
1 |
0.0002 |
| 161 |
RENAL FUNCTION TEST ABNORMAL |
1 |
0.0002 |
| 162 |
NEPHROPATHY |
2 |
0.0002 |
| 163 |
VAGINAL INFECTION |
1 |
0.0002 |
| 164 |
COLITIS MICROSCOPIC |
1 |
0.0002 |
| 165 |
DEVICE LEAKAGE |
9 |
0.0002 |
| 166 |
NEEDLE ISSUE |
6 |
0.0002 |
| 167 |
NASAL CONGESTION |
12 |
0.0002 |
| 168 |
HYPERVOLAEMIA |
1 |
0.0002 |
| 169 |
ABDOMINAL TENDERNESS |
1 |
0.0002 |
| 170 |
FLUID INTAKE REDUCED |
1 |
0.0002 |
| 171 |
PRODUCT COLOUR ISSUE |
1 |
0.0002 |
| 172 |
RESPIRATORY TRACT INFECTION |
5 |
0.0002 |
| 173 |
PETECHIAE |
2 |
0.0002 |
| 174 |
JOINT STIFFNESS |
5 |
0.0002 |
| 175 |
FOOD POISONING |
1 |
0.0002 |
| 176 |
PHARYNGITIS STREPTOCOCCAL |
2 |
0.0002 |
| 177 |
BLOOD CREATININE INCREASED |
12 |
0.0002 |
| 178 |
OROPHARYNGEAL PAIN |
17 |
0.0002 |
| 179 |
PRODUCT PHYSICAL CONSISTENCY ISSUE |
1 |
0.0002 |
| 180 |
INJECTION SITE INJURY |
1 |
0.0002 |
| 181 |
STREPTOCOCCAL INFECTION |
1 |
0.0002 |
| 182 |
INTRACRANIAL PRESSURE INCREASED |
1 |
0.0002 |
| 183 |
DERMATITIS CONTACT |
2 |
0.0002 |
| 184 |
MOUTH SWELLING |
1 |
0.0002 |
| 185 |
BLOOD URIC ACID INCREASED |
1 |
0.0002 |
| 186 |
DEVICE USE ERROR |
6 |
0.0002 |
| 187 |
SYRINGE ISSUE |
3 |
0.0002 |
| 188 |
URINE ODOUR ABNORMAL |
1 |
0.0002 |
| 189 |
COVID-19 PNEUMONIA |
2 |
0.0002 |
| 190 |
GLUCOSE TOLERANCE IMPAIRED |
1 |
0.0002 |
| 191 |
CATARACT OPERATION |
1 |
0.0002 |
| 192 |
THIRST |
3 |
0.0002 |
| 193 |
DEVICE ISSUE |
15 |
0.0002 |
| 194 |
GOUT |
3 |
0.0002 |
| 195 |
RENAL IMPAIRMENT |
14 |
0.0002 |
| 196 |
GANGRENE |
1 |
0.0002 |
| 197 |
OLIGURIA |
1 |
0.0002 |
| 198 |
BLEPHAROSPASM |
1 |
0.0002 |
| 199 |
BRONCHIECTASIS |
1 |
0.0001 |
| 200 |
SINUS CONGESTION |
2 |
0.0001 |
| 201 |
BODY TEMPERATURE INCREASED |
3 |
0.0001 |
| 202 |
SKIN REACTION |
2 |
0.0001 |
| 203 |
PAPULE |
1 |
0.0001 |
| 204 |
VISUAL FIELD DEFECT |
1 |
0.0001 |
| 205 |
SENSITIVE SKIN |
1 |
0.0001 |
| 206 |
SNEEZING |
3 |
0.0001 |
| 207 |
KETOACIDOSIS |
1 |
0.0001 |
| 208 |
GENERAL SYMPTOM |
1 |
0.0001 |
| 209 |
TENDON PAIN |
1 |
0.0001 |
| 210 |
GASTROINTESTINAL INFLAMMATION |
1 |
0.0001 |
| 211 |
BRAIN FOG |
2 |
0.0001 |
| 212 |
ELECTROCARDIOGRAM ABNORMAL |
1 |
0.0001 |
| 213 |
NASAL DISCOMFORT |
1 |
0.0001 |
| 214 |
GINGIVAL PAIN |
1 |
0.0001 |
| 215 |
BLOOD PRESSURE FLUCTUATION |
3 |
0.0001 |
| 216 |
POST PROCEDURAL INFECTION |
1 |
0.0001 |
| 217 |
SWELLING FACE |
8 |
0.0001 |
| 218 |
ASPHYXIA |
1 |
0.0001 |
| 219 |
POLYURIA |
1 |
0.0001 |
| 220 |
INFLUENZA LIKE ILLNESS |
10 |
0.0001 |
| 221 |
UPPER-AIRWAY COUGH SYNDROME |
1 |
0.0001 |
| 222 |
PHOTOSENSITIVITY REACTION |
2 |
0.0001 |
| 223 |
MENSTRUAL DISORDER |
1 |
0.0001 |
| 224 |
EYE PRURITUS |
4 |
0.0001 |
| 225 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
2 |
0.0001 |
| 226 |
HYSTERECTOMY |
1 |
0.0001 |
| 227 |
SKIN SWELLING |
1 |
0.0001 |
| 228 |
INCORRECT DOSE ADMINISTERED BY DEVICE |
3 |
0.0001 |
| 229 |
COUGH |
32 |
0.0001 |
| 230 |
PURPURA |
1 |
0.0001 |
| 231 |
GASTROINTESTINAL INFECTION |
1 |
0.0001 |
| 232 |
TOOTHACHE |
2 |
0.0001 |
| 233 |
PNEUMONIA BACTERIAL |
1 |
0.0001 |
| 234 |
NERVE COMPRESSION |
1 |
0.0001 |
| 235 |
WRONG TECHNIQUE IN DEVICE USAGE PROCESS |
5 |
0.0001 |
| 236 |
PRODUCT DOSE OMISSION IN ERROR |
3 |
0.0001 |
| 237 |
SPUTUM DISCOLOURED |
1 |
0.0001 |
| 238 |
POST PROCEDURAL COMPLICATION |
2 |
0.0001 |
| 239 |
PERIPHERAL SWELLING |
16 |
0.0001 |
| 240 |
DIZZINESS POSTURAL |
1 |
0.0001 |
| 241 |
AUTOIMMUNE DISORDER |
1 |
0.0001 |
| 242 |
VITAMIN D DEFICIENCY |
1 |
0.0001 |
| 243 |
LIGAMENT SPRAIN |
1 |
0.0001 |
| 244 |
SINUS DISORDER |
2 |
0.0001 |
| 245 |
BLADDER DISORDER |
1 |
0.0001 |
| 246 |
BLOOD PRESSURE ABNORMAL |
2 |
0.0001 |
| 247 |
HYPOTONIA |
1 |
0.0001 |
| 248 |
OVARIAN CYST |
1 |
0.0001 |
| 249 |
DEVICE BREAKAGE |
4 |
0.0001 |
| 250 |
DRY THROAT |
1 |
0.0001 |
| 251 |
SLUGGISHNESS |
1 |
0.0001 |
| 252 |
INITIAL INSOMNIA |
1 |
0.0001 |
| 253 |
DEPRESSED MOOD |
5 |
0.0001 |
| 254 |
LIVER FUNCTION TEST INCREASED |
2 |
0.0001 |
| 255 |
MENSTRUATION DELAYED |
1 |
0.0001 |
| 256 |
BLOOD PRESSURE DECREASED |
6 |
0.0001 |
| 257 |
SINUSITIS |
9 |
0.0001 |
| 258 |
FATIGUE |
68 |
0.0001 |
| 259 |
ALOPECIA |
17 |
0.0001 |
| 260 |
PERICARDIAL EFFUSION |
2 |
0.0001 |
| 261 |
HYPERSENSITIVITY |
16 |
0.0001 |
| 262 |
ELECTROLYTE IMBALANCE |
1 |
0.0001 |
| 263 |
SWELLING |
8 |
0.0001 |
| 264 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
17 |
0.0001 |
| 265 |
NOCTURIA |
1 |
0.0001 |
| 266 |
PRESYNCOPE |
2 |
0.0001 |
| 267 |
SPINAL OPERATION |
1 |
0.0001 |
| 268 |
INJECTION SITE MASS |
3 |
0.0001 |
| 269 |
DYSGEUSIA |
6 |
0.0001 |
| 270 |
PHARYNGITIS |
1 |
0.0001 |
| 271 |
HAIR COLOUR CHANGES |
1 |
0.0001 |
| 272 |
ABDOMINAL PAIN LOWER |
2 |
0.0001 |
| 273 |
FLUID RETENTION |
4 |
0.0001 |
| 274 |
HAEMATOMA |
2 |
0.0001 |
| 275 |
IMMUNE SYSTEM DISORDER |
1 |
0.0001 |
| 276 |
TOOTH INFECTION |
1 |
0.0001 |
| 277 |
PULMONARY CONGESTION |
1 |
0.0001 |
| 278 |
FREQUENT BOWEL MOVEMENTS |
2 |
0.0001 |
| 279 |
OEDEMA |
4 |
0.0001 |
| 280 |
FEELING COLD |
2 |
0.0001 |
| 281 |
HUNGER |
1 |
0.0001 |
| 282 |
INFLUENZA |
8 |
0.0001 |
| 283 |
APHONIA |
1 |
0.0001 |
| 284 |
SKIN EXFOLIATION |
6 |
0.0001 |
| 285 |
IMPAIRED QUALITY OF LIFE |
1 |
0.0001 |
| 286 |
BACK PAIN |
16 |
0.0001 |
| 287 |
APATHY |
1 |
0.0001 |
| 288 |
PRODUCT STORAGE ERROR |
6 |
0.0001 |
| 289 |
GASTROENTERITIS |
1 |
0.0001 |
| 290 |
OESOPHAGEAL CARCINOMA |
2 |
0.0001 |
| 291 |
PULMONARY MASS |
1 |
0.0001 |
| 292 |
RESPIRATORY DISORDER |
2 |
0.0001 |
| 293 |
VERTIGO |
4 |
0.0001 |
| 294 |
NEPHROLITHIASIS |
3 |
0.0001 |
| 295 |
RESPIRATORY TRACT CONGESTION |
1 |
0.0001 |
| 296 |
PRODUCTIVE COUGH |
3 |
0.0001 |
| 297 |
SCIATICA |
1 |
0.0001 |
| 298 |
INJECTION SITE HAEMORRHAGE |
5 |
0.0001 |
| 299 |
CONTUSION |
6 |
0.0001 |
| 300 |
SENSORY DISTURBANCE |
1 |
0.0001 |
| 301 |
DYSPEPSIA |
6 |
0.0001 |
| 302 |
PYREXIA |
21 |
0.0001 |
| 303 |
VIRAL INFECTION |
2 |
0.0001 |
| 304 |
BLOOD UREA INCREASED |
1 |
0.0001 |
| 305 |
CANDIDA INFECTION |
1 |
0.0001 |
| 306 |
URINARY TRACT INFECTION |
10 |
0.0001 |
| 307 |
DIZZINESS |
29 |
0.0001 |
| 308 |
INFLAMMATION |
3 |
0.0001 |
| 309 |
MUSCULOSKELETAL DISCOMFORT |
1 |
0.0001 |
| 310 |
PRODUCT DOSE OMISSION ISSUE |
17 |
0.0001 |
| 311 |
ORTHOSTATIC HYPOTENSION |
1 |
0.0001 |
| 312 |
NERVOUSNESS |
3 |
0.0001 |
| 313 |
RASH MACULAR |
2 |
0.0001 |
| 314 |
BLOOD TRIGLYCERIDES INCREASED |
1 |
0.0001 |
| 315 |
HEAD DISCOMFORT |
1 |
0.0001 |
| 316 |
ADVERSE DRUG REACTION |
5 |
0.0001 |
| 317 |
GASTROENTERITIS VIRAL |
1 |
0.0001 |
| 318 |
RASH PRURITIC |
3 |
0.0001 |
| 319 |
HYPOTENSION |
11 |
0.0001 |
| 320 |
END STAGE RENAL DISEASE |
1 |
0.0001 |
| 321 |
PRURITUS |
21 |
0.0001 |
| 322 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
1 |
0.0001 |
| 323 |
CONJUNCTIVITIS |
1 |
0.0001 |
| 324 |
NECK PAIN |
3 |
0.0001 |
| 325 |
ABDOMINAL DISCOMFORT |
9 |
0.0001 |
| 326 |
MIDDLE INSOMNIA |
1 |
0.0001 |
| 327 |
ERYTHEMA |
11 |
0.0001 |
| 328 |
HYPOAESTHESIA |
8 |
0.0001 |
| 329 |
BLISTER |
3 |
0.0001 |
| 330 |
MUSCULAR WEAKNESS |
6 |
0.0001 |
| 331 |
SLEEP APNOEA SYNDROME |
1 |
0.0001 |
| 332 |
INCREASED APPETITE |
1 |
0.0001 |
| 333 |
BLOOD PRESSURE INCREASED |
8 |
0.0001 |
| 334 |
LETHARGY |
3 |
0.0001 |
| 335 |
PULMONARY FIBROSIS |
1 |
0.0001 |
| 336 |
BLOOD PRESSURE SYSTOLIC INCREASED |
1 |
0.0001 |
| 337 |
ORAL HERPES |
1 |
0.0001 |
| 338 |
CHILLS |
6 |
0.0001 |
| 339 |
DISORIENTATION |
2 |
0.0001 |
| 340 |
IRRITABILITY |
3 |
0.0000 |
| 341 |
JOINT SWELLING |
6 |
0.0000 |
| 342 |
PRODUCT PHYSICAL ISSUE |
1 |
0.0000 |
| 343 |
TASTE DISORDER |
1 |
0.0000 |
| 344 |
INJURY ASSOCIATED WITH DEVICE |
1 |
0.0000 |
| 345 |
BLINDNESS |
2 |
0.0000 |
| 346 |
MUSCLE SPASMS |
9 |
0.0000 |
| 347 |
POLLAKIURIA |
2 |
0.0000 |
| 348 |
ABDOMINAL DISTENSION |
5 |
0.0000 |
| 349 |
DERMATITIS |
1 |
0.0000 |
| 350 |
RETCHING |
1 |
0.0000 |
| 351 |
POOR QUALITY SLEEP |
1 |
0.0000 |
| 352 |
PRODUCT PRESCRIBING ISSUE |
1 |
0.0000 |
| 353 |
CLOSTRIDIUM DIFFICILE INFECTION |
1 |
0.0000 |
| 354 |
RASH PAPULAR |
1 |
0.0000 |
| 355 |
THROAT IRRITATION |
2 |
0.0000 |
| 356 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
8 |
0.0000 |
| 357 |
PAIN IN EXTREMITY |
13 |
0.0000 |
| 358 |
SKIN IRRITATION |
2 |
0.0000 |
| 359 |
INJECTION SITE REACTION |
3 |
0.0000 |
| 360 |
NEURALGIA |
1 |
0.0000 |
| 361 |
ARTHRALGIA |
17 |
0.0000 |
| 362 |
NAUSEA |
32 |
0.0000 |
| 363 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
1 |
0.0000 |
| 364 |
GASTRIC CANCER |
1 |
0.0000 |
| 365 |
RASH |
17 |
0.0000 |
| 366 |
MALAISE |
17 |
0.0000 |
| 367 |
DIPLOPIA |
1 |
0.0000 |
| 368 |
HEADACHE |
24 |
0.0000 |
| 369 |
DEAFNESS |
1 |
0.0000 |
| 370 |
ECZEMA |
2 |
0.0000 |
| 371 |
GASTRITIS |
1 |
0.0000 |
| 372 |
DEHYDRATION |
5 |
0.0000 |
| 373 |
MENSTRUATION IRREGULAR |
1 |
0.0000 |
| 374 |
GASTROOESOPHAGEAL REFLUX DISEASE |
3 |
0.0000 |
| 375 |
SKIN LESION |
1 |
0.0000 |
| 376 |
HAEMATOCHEZIA |
2 |
0.0000 |
| 377 |
DIVERTICULITIS |
1 |
0.0000 |
| 378 |
PROCEDURAL PAIN |
1 |
0.0000 |
| 379 |
DIARRHOEA |
23 |
0.0000 |
| 380 |
RED BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 381 |
HYPERSOMNIA |
1 |
0.0000 |
| 382 |
INFECTION |
5 |
0.0000 |
| 383 |
DYSSTASIA |
1 |
0.0000 |
| 384 |
ABDOMINAL PAIN UPPER |
7 |
0.0000 |
| 385 |
WHEEZING |
2 |
0.0000 |
| 386 |
GASTROINTESTINAL DISORDER |
3 |
0.0000 |
| 387 |
BLOOD POTASSIUM DECREASED |
1 |
0.0000 |
| 388 |
LACRIMATION INCREASED |
1 |
0.0000 |
| 389 |
HYPERTENSION |
7 |
0.0000 |
| 390 |
CONSTIPATION |
7 |
0.0000 |
| 391 |
SWOLLEN TONGUE |
1 |
0.0000 |
| 392 |
HEAD INJURY |
1 |
0.0000 |
| 393 |
PULMONARY EMBOLISM |
3 |
0.0000 |
| 394 |
NIGHT SWEATS |
1 |
0.0000 |
| 395 |
EXPIRED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 396 |
INSOMNIA |
8 |
0.0000 |
| 397 |
FUNGAL INFECTION |
1 |
0.0000 |
| 398 |
SOMNOLENCE |
6 |
0.0000 |
| 399 |
TYPE 2 DIABETES MELLITUS |
1 |
0.0000 |
| 400 |
MYALGIA |
5 |
0.0000 |
| 401 |
ASTHENIA |
11 |
0.0000 |
| 402 |
WEIGHT DECREASED |
8 |
0.0000 |
| 403 |
COVID-19 |
5 |
0.0000 |
| 404 |
HEART RATE DECREASED |
1 |
0.0000 |
| 405 |
LYMPHADENOPATHY |
1 |
0.0000 |
| 406 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
2 |
0.0000 |
| 407 |
VOMITING |
13 |
0.0000 |
| 408 |
RESTLESSNESS |
1 |
0.0000 |
| 409 |
DYSURIA |
1 |
0.0000 |
| 410 |
HEPATIC FUNCTION ABNORMAL |
1 |
0.0000 |
| 411 |
DYSPNOEA EXERTIONAL |
1 |
0.0000 |
| 412 |
HOT FLUSH |
2 |
0.0000 |
| 413 |
PALPITATIONS |
3 |
0.0000 |
| 414 |
DRUG DOSE OMISSION BY DEVICE |
2 |
0.0000 |
| 415 |
ARTHRITIS |
2 |
0.0000 |
| 416 |
FEELING ABNORMAL |
6 |
0.0000 |
| 417 |
HYPOACUSIS |
1 |
0.0000 |
| 418 |
DEVICE DISLOCATION |
1 |
0.0000 |
| 419 |
MUSCULOSKELETAL STIFFNESS |
2 |
0.0000 |
| 420 |
PAIN |
14 |
0.0000 |
| 421 |
ANGIOEDEMA |
1 |
0.0000 |
| 422 |
DRY SKIN |
3 |
0.0000 |
| 423 |
MATERNAL EXPOSURE DURING PREGNANCY |
2 |
0.0000 |
| 424 |
PULMONARY OEDEMA |
1 |
0.0000 |
| 425 |
VISION BLURRED |
3 |
0.0000 |
| 426 |
TINNITUS |
1 |
0.0000 |
| 427 |
ADVERSE EVENT |
2 |
0.0000 |
| 428 |
PNEUMONIA |
7 |
0.0000 |
| 429 |
CHEST PAIN |
4 |
0.0000 |
| 430 |
DECREASED APPETITE |
5 |
0.0000 |
| 431 |
RENAL DISORDER |
1 |
0.0000 |
| 432 |
BLOOD CHOLESTEROL INCREASED |
1 |
0.0000 |
| 433 |
ARRHYTHMIA |
1 |
0.0000 |
| 434 |
MIGRAINE |
2 |
0.0000 |
| 435 |
BLOOD GLUCOSE DECREASED |
1 |
0.0000 |
| 436 |
HYPOGLYCAEMIA |
1 |
0.0000 |
| 437 |
DRY EYE |
1 |
0.0000 |
| 438 |
CELLULITIS |
1 |
0.0000 |
| 439 |
ACUTE KIDNEY INJURY |
3 |
0.0000 |
| 440 |
CHEST DISCOMFORT |
2 |
0.0000 |
| 441 |
PARAESTHESIA |
3 |
0.0000 |
| 442 |
DISTURBANCE IN ATTENTION |
1 |
0.0000 |
| 443 |
URTICARIA |
3 |
0.0000 |
| 444 |
WEIGHT INCREASED |
4 |
0.0000 |
| 445 |
HYPONATRAEMIA |
1 |
0.0000 |
| 446 |
EYE PAIN |
1 |
0.0000 |
| 447 |
FLATULENCE |
1 |
0.0000 |
| 448 |
DEPRESSION |
4 |
0.0000 |
| 449 |
HERPES ZOSTER |
1 |
0.0000 |
| 450 |
EYE IRRITATION |
1 |
0.0000 |
| 451 |
DYSPHONIA |
1 |
0.0000 |
| 452 |
BONE PAIN |
1 |
0.0000 |
| 453 |
DISEASE PROGRESSION |
2 |
0.0000 |
| 454 |
ILL-DEFINED DISORDER |
1 |
0.0000 |
| 455 |
PLEURAL EFFUSION |
1 |
0.0000 |
| 456 |
DISCOMFORT |
1 |
0.0000 |
| 457 |
VISUAL IMPAIRMENT |
2 |
0.0000 |
| 458 |
BLOOD GLUCOSE INCREASED |
3 |
0.0000 |
| 459 |
DEEP VEIN THROMBOSIS |
1 |
0.0000 |
| 460 |
RENAL FAILURE |
2 |
0.0000 |
| 461 |
HEPATIC ENZYME INCREASED |
1 |
0.0000 |
| 462 |
INJURY |
1 |
0.0000 |
| 463 |
SKIN BURNING SENSATION |
1 |
0.0000 |
| 464 |
OFF LABEL USE |
12 |
0.0000 |
| 465 |
BRONCHITIS |
1 |
0.0000 |
| 466 |
EPISTAXIS |
1 |
0.0000 |
| 467 |
ACNE |
1 |
0.0000 |
| 468 |
INCORRECT DOSE ADMINISTERED |
3 |
0.0000 |
| 469 |
ABDOMINAL PAIN |
3 |
0.0000 |
| 470 |
CARDIAC FAILURE |
1 |
0.0000 |
| 471 |
CARDIAC FAILURE CONGESTIVE |
1 |
0.0000 |
| 472 |
THROMBOSIS |
1 |
0.0000 |
| 473 |
DRY MOUTH |
1 |
0.0000 |
| 474 |
TREMOR |
2 |
0.0000 |
| 475 |
INTENTIONAL PRODUCT USE ISSUE |
1 |
0.0000 |
| 476 |
ANXIETY |
3 |
0.0000 |
| 477 |
NEUROPATHY PERIPHERAL |
1 |
0.0000 |
| 478 |
ANAEMIA |
2 |
0.0000 |
| 479 |
GAIT DISTURBANCE |
2 |
0.0000 |
| 480 |
ATRIAL FIBRILLATION |
1 |
0.0000 |
| 481 |
HEART RATE INCREASED |
1 |
0.0000 |
| 482 |
SYNCOPE |
1 |
0.0000 |
| 483 |
HAEMOGLOBIN DECREASED |
1 |
0.0000 |
| 484 |
ACCIDENTAL EXPOSURE TO PRODUCT |
1 |
0.0000 |
| 485 |
HAEMORRHAGE |
1 |
0.0000 |
| 486 |
WHITE BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 487 |
SEPSIS |
1 |
0.0000 |
| 488 |
DYSPNOEA |
5 |
0.0000 |
| 489 |
RHEUMATOID ARTHRITIS |
1 |
0.0000 |
| 490 |
OEDEMA PERIPHERAL |
1 |
0.0000 |
| 491 |
LOSS OF CONSCIOUSNESS |
1 |
0.0000 |
| 492 |
HYPERHIDROSIS |
1 |
0.0000 |
| 493 |
DRUG INEFFECTIVE |
10 |
0.0000 |
| 494 |
MEMORY IMPAIRMENT |
1 |
0.0000 |
| 495 |
HOSPITALISATION |
1 |
0.0000 |
| 496 |
CONFUSIONAL STATE |
1 |
0.0000 |
| 497 |
CEREBROVASCULAR ACCIDENT |
1 |
0.0000 |
| 498 |
DEATH |
3 |
0.0000 |
| 499 |
CONDITION AGGRAVATED |
1 |
0.0000 |
| 500 |
FALL |
1 |
0.0000 |